
About Dr. Viviana Bozón

About Dr. Viviana Bozon
Viviana stands at the forefront of drug development as an executive with more than twenty years of global experience. Her reputation as an entrepreneurial leader is anchored in her demonstrated capability to navigate and advance impactful clinical strategies, thereby fast-tracking organizational growth. Fueled by a deep-seated commitment to positively impact the lives of patients in clinical trials, Viviana has engaged in an exhaustive involvement across the medical spectrum of drug development.
Her journey spans from the initial stages of pre-IND through to NDA submissions and extends even further. Viviana holds a firm belief in the necessity of a thorough and varied implementation of clinical programs, which she sees as essential for validating the complex benefit/risk assessments that patients face. This approach not only broadens the reach to encompass a more diverse patient population but also contributes significantly to the progress of scientific research.
As a Chief Medical Officer, Dr. Bozon oversees clinical strategy and operations, ensuring the development of innovative therapies that meet the highest standards of medical science and patient care.
Professional Affiliations:
• American Society of Clinical Oncology (ASCO): As a member of ASCO, Dr. Bozon actively participates in the organization’s efforts to advance cancer treatment through research, education, and the promotion of high-quality patient care.
• American Association for Cancer Research (AACR): Dr. Bozon is a dedicated member of AACR, contributing to the collective goal of preventing and curing cancer through groundbreaking scientific research and collaboration.
• Society for Melanoma Research (SMR): With a focus on melanoma, Dr. Bozon’s involvement in SMR underscores her commitment to advancing the understanding and treatment of melanoma through cutting-edge research and clinical excellence.
Dr. Bozon is recognized for her contributions to oncology and has authored numerous publications in leading medical journals. Her leadership and vision continue to drive her personal mission to bring transformative therapies to patients in need.
Dr. Viviana Bozón’s illustrious career in the pharmaceutical and biotech sectors is distinguished by progressive leadership roles and significant contributions to medical and clinical development. Her professional journey is highlighted by pivotal positions at leading companies:
Ribon Therapeutics
Senior Vice-President at Ribon Therapeutics (2020-2023): Dr. Bozón led pivotal drug development initiatives, contributing to Ribon’s growth and innovation in the biotech landscape.
Fosun Pharma
Chief Medical Officer, Ex-China at Fosun Pharma (2018-2020): She spearheaded medical and clinical strategies outside China, enhancing Fosun Pharma’s global presence and impact.
EMD Serono
Senior Medical Director, US Medical Affairs at EMD Serono (2017-2018): In this role, she played a key part in shaping the medical affairs strategy in the United States, further establishing EMD Serono’s commitment to medical excellence.
Array Biopharma
Senior Medical Director at Array Biopharma (2015-2017): Dr. Bozón was instrumental in advancing Array Biopharma’s clinical development portfolio, demonstrating her expertise in leading complex clinical programs.
Takeda
Medical Director at Takeda (2008-2015): Her tenure at Takeda was marked by significant contributions to clinical programs and medical affairs initiatives, showcasing her ability to drive medical strategy and execution.
Pfizer
Senior Medical Director, Global Medical Affairs and Clinical Development at Pfizer Inc. (1997-2008): Dr. Bozón commenced her career at Pfizer, where she laid the foundation for her expertise in drug development and global medical strategy.

Let’s get in touch
Dr. Bozón’s career is characterized by her deep commitment to advancing healthcare through strategic leadership and innovation in drug development.
